期刊文献+

蚕丝蛋白和明胶复合组织工程材料与肝细胞相容性的实验研究 被引量:1

Experimental Study on Silk Protein-Three-dimensional Gelatin Scaffold and Compatibility of Liver Cells
原文传递
导出
摘要 目的:研究蚕丝蛋白-明胶三维材料支架对人永生化肝细胞系QZG贴附及增殖的影响。方法:采用四氮唑盐比色法(MTT)、细胞计数法检测QZG细胞在纯蚕丝生物材料上与在蚕丝蛋白-明胶复合材料上的增殖情况,用扫描电镜观察QZG细胞在两种三维生物材料上的贴附与增殖情况。结果:QZG细胞可以在蚕丝蛋白生物材料贴附及增殖,在引入明胶的蚕丝蛋白材料上细胞贴附更紧密,增殖更明显。结论:蚕丝蛋白与明胶复合材料支架具有良好的细胞贴附性能,通过改进在肝组织工程应用方面将具有一定应用前景。 Objective: To study the silk fibroin material's effect on proliferation of human normal hepatic cell line QZG,and to testify the cytocompatibility when blending of silk fibroin and gelatin into 3D scaffold.Methods:The activity of cell proliferation and relative growth rate(RGR) were assessed by MTT colorimetric assay and viable cell counting,The effect of silk protein materials on growth of cells was observed by scanning electron microscopy(SEM).Results: Human normal hepatic cell line QZG were cultivated in vitro directly on pure silk protein materials and silk fibroin/ gelatin materials.Cells solidly adhered to the materials.The activity of cell proliferation on silk fibroin/ gelatin materials was significantly more than that in the group of pure silk fibroin materials.The result of viable cell counting was compatible to MTT colorimetric assay.Conclusion:The silk fibroin materials together with gelatin has a good cytocompatibility with human normal hepatic cell line QZG.It will be useful in liver tissue engineering.
出处 《现代生物医学进展》 CAS 2011年第8期1432-1435,共4页 Progress in Modern Biomedicine
基金 国家863计划(2009AA043801)
关键词 MTT比色法 蚕丝蛋白 明胶 肝组织工程 细胞相容性. MTT Silk protein Gelatin Liver tissue engineering
  • 相关文献

参考文献20

  • 1JIN H J,KAPLAN David.Mechanism of silk processing in insects and spide [ J ].Nature,2003,424(6952): 1057- 1061.
  • 2秦胜男,陈鸿辉.胶原在软骨组织工程中的应用[J].中国矫形外科杂志,2009,17(13):998-1000. 被引量:10
  • 3Cirillo B, Morra M, Catapano G. Adhesion and function of rat liver cells adherent to silk fibroin/collagen blend films [J]. Int J Artif Organs, 2004,27(1):60-68.
  • 4Naoya Kobayashi. Life support of artificial liver: development of a bioartificial liver to treat liver failure. J Hepatobiliary Pancreat Surg 2009; 16(2): 113-117.
  • 5国家医药管理局医用高分子产品质量检测中心.GB/T16886.6-1997,医疗器械生物学评价--第6部分:植入后局部反应试验[S].北京:中国标准出版社,1997:92-98.
  • 6国家医药管理局医用高分子产品质量检测中心.GB/T16886.11-1997医疗器械生物学评价-第11部分:全身毒性试验[S].北京:中国标准出版社,1997:177-183.
  • 7Johnson ILl, Northup S J, Seagraves PA, et al. Biocompatibility test p roeedures formaterials evaluation in vitro. I. Comparative test system sensitivity[J]. J Biomed Mater Res, 1983, 17 (4) : 571 - 586.
  • 8金鸿莱,黄哲玮,陆华,束蓉.多西环素纳米脂质体缓释凝胶生物相容性及细胞毒性[J].上海交通大学学报(医学版),2007,27(6):649-651. 被引量:5
  • 9Winkler S, Kaplan DL. Molecular biology of spider silk [ J ].Rev Mol Biotech, 2000,74: 85-93.
  • 10Heslot H. Atificial fibrous proteins: a review. Biochimie, 1998,80: 19-31.

二级参考文献45

共引文献17

同被引文献39

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部